Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer in a transgenic mouse

N M Greenberg1, F DeMayo, M J Finegold

  • 1Department of Cell Biology, Baylor College of Medicine, Houston, TX 77030, USA.

Proceedings of the National Academy of Sciences of the United States of America
|April 11, 1995
PubMed
Summary

Researchers developed a new transgenic mouse model for prostate cancer. These mice spontaneously develop tumors resembling human prostate cancer, aiding research into this disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TAp63 suppresses mammary tumorigenesis through regulation of the Hippo pathway.

Oncogene·2016
Same author

Uterine RAC1 via Pak1-ERM signaling directs normal luminal epithelial integrity conducive to on-time embryo implantation in mice.

Cell death and differentiation·2015
Same author

Antenatal corticosteroids and perinatal outcomes in infants born at 23-25 weeks of gestation.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2014
Same author

Stage specificity of selenium-mediated inhibition of mouse mammary tumorigenesis.

Biological trace element research·2013
Same author

Selenium retention and inhibition of cell growth in mouse mammary epithelial cell lines in vitro.

Biological trace element research·2013
Same author

Rash in an eight-year-old boy.

American family physician·2013

Area of Science:

  • Oncology
  • Genetics
  • Animal Models

Background:

  • Understanding prostate cancer biology is limited by a lack of suitable animal models.
  • Prostate cancer is a uniquely human disease, posing challenges for research.

Purpose of the Study:

  • To create a reliable animal model for studying prostate cancer progression.
  • To investigate the molecular mechanisms underlying prostate cancer development and metastasis.

Main Methods:

  • Generation of transgenic mice using the rat probasin promoter to express simian virus 40 large tumor antigen.
  • Histological and immunohistochemical analysis of prostate tissues in developed mouse models.
  • Monitoring for tumor development and characterizing molecular markers like p53 and androgen receptor.

Related Experiment Videos

Main Results:

  • Transgenic mice developed progressive prostatic disease, including intraepithelial hyperplasia and malignant neoplasia, mimicking human prostate cancer.
  • Prostate tumors were detected as early as 10 weeks of age.
  • Tumor tissues showed altered p53 and androgen receptor expression patterns consistent with advanced human prostate cancer.

Conclusions:

  • The established transgenic mouse lines provide a reproducible model for prostate cancer research.
  • This model facilitates the study of normal prostatic cell transformation and metastatic progression.
  • Further research can explore the molecular basis of prostate cancer using this new animal system.